Showing results (91-100 of 137) with videos related to

Sort By:
Pageof 14
Trials|December 13, 2025
The SHARE study - Survivorship After Head and Neck Cancer: evaluating patient care and adherence to follow up in Ontario, Canada: study protocol for a randomized controlled trialBilly Tran, Agnieszka Dzioba, Jennifer Baker, et al.
BMC Cancer|March 22, 2013
Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR)--study protocol for a randomized phase II trialAnthony C Nichols, John Yoo, J Alex Hammond, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2020
PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell CarcinomaFederica Ganci, Claudio Pulito, Sara Valsoni, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|May 10, 2012
Ki-67 expression predicts radiotherapy failure in early glottic cancerAnthony C Nichols, Fiona Whelan, John Basmaji, et al.
Journal of Medical Imaging and Radiation Sciences|October 12, 2021
Implementation and evaluation of an online anatomy, radiology and contouring bootcamp for radiation therapistsKrista D'Angelo, Paige Eansor, Leah A D'Souza, et al.
Plos One|September 24, 2020
Flavopiridol causes cell cycle inhibition and demonstrates anti-cancer activity in anaplastic thyroid cancer modelsNicole Pinto, Stephenie D Prokopec, Farhad Ghasemi, et al.
Head & Neck|February 21, 2022
Tumor molecular differences associated with outcome disparities of Black patients with head and neck cancerHugh A J Kim, Peter Y F Zeng, Alana Sorgini, et al.
Cell Reports. Medicine|May 16, 2026
Understanding and overcoming innate and acquired MAPK inhibition resistance in anaplastic thyroid cancerPeter Y F Zeng, Jalna Meens, Amir Hossein Karimi, et al.
Oncotarget|October 27, 2017
Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancerFarhad Ghasemi, Morgan Black, Frederick Vizeacoumar, et al.
Head & Neck|December 7, 2023
HPV-negative head and neck cancers with adverse pathological features carry specific molecular changes that are associated with survivalHugh Andrew Jinwook Kim, Peter Y F Zeng, Matthew Cecchini, et al.
Pageof 14